Process View
Any process that modulates the frequency, rate or extent of interleukin-10 secretion.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of interleukin 10 secretion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.994 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.992 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.987 | ||
| BTN3A3 | butyrophilin, subfamily 3, member A3 | 0.983 | Human | |
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.951 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.940 | Human | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.921 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.876 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.851 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.846 | Human | |
| BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.786 | Human | |
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.773 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.750 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.730 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.727 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.507 | Human | |
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.465 | Human | |
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.437 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.383 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.364 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.358 | Human | |
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.352 | Human | |
| CD80 | CD80 molecule | 0.340 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.336 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.232 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.164 | ||
| MEFV | Mediterranean fever | 0.154 | ||
| HCP5 | HLA complex P5 | 0.147 | ||
| PTAFR | platelet-activating factor receptor | 0.111 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.110 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.108 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.088 | Human | |
| HK3 | hexokinase 3 (white cell) | 0.082 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.077 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.071 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.069 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.062 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.058 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.045 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.043 | ||
| CSK | c-src tyrosine kinase | 0.041 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.040 | ||
| NUMB | numb homolog (Drosophila) | 0.037 | ||
| NLRC5 | NLR family, CARD domain containing 5 | 0.037 | ||
| UBA7 | ubiquitin-like modifier activating enzyme 7 | 0.036 | ||
| CD86 | CD86 molecule | 0.032 | Human | |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.032 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.031 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.031 | ||
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.031 | ||
| CD33 | CD33 molecule | 0.031 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.031 | ||
| ZNF71 | zinc finger protein 71 | 0.030 | ||
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.029 | ||
| CD300C | CD300c molecule | 0.028 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.027 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.027 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.025 | Human | |
| RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.025 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.025 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.024 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.024 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.023 | ||
| SLC15A3 | solute carrier family 15, member 3 | 0.023 | ||
| RASSF4 | Ras association (RalGDS/AF-6) domain family member 4 | 0.023 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.022 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.021 | ||
| TFF1 | trefoil factor 1 | 0.021 | ||
| RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.021 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.020 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.020 | ||
| NMT2 | N-myristoyltransferase 2 | 0.020 | ||
| APOL3 | apolipoprotein L, 3 | 0.019 | ||
| TLR8 | toll-like receptor 8 | 0.019 | ||
| CD72 | CD72 molecule | 0.019 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.019 | ||
| LGALS9 | lectin, galactoside-binding, soluble, 9 | 0.019 | ||
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.018 | Human | |
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.018 | ||
| IRF8 | interferon regulatory factor 8 | 0.018 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.018 | Human | |
| APOL1 | apolipoprotein L, 1 | 0.018 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.017 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.017 | ||
| EXT2 | exostosin 2 | 0.017 | ||
| BTN2A1 | butyrophilin, subfamily 2, member A1 | 0.017 | Human | |
| CYTH4 | cytohesin 4 | 0.017 | ||
| FPR2 | formyl peptide receptor 2 | 0.017 | ||
| MARCH1 | membrane-associated ring finger (C3HC4) 1 | 0.017 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.017 | ||
| PHF11 | PHD finger protein 11 | 0.017 | ||
| CD1D | CD1d molecule | 0.016 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.016 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.016 | ||
| AIM2 | absent in melanoma 2 | 0.016 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.016 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.016 | ||
| ERAP2 | endoplasmic reticulum aminopeptidase 2 | 0.015 | ||
| AIF1 | allograft inflammatory factor 1 | 0.015 | ||
| ADPRH | ADP-ribosylarginine hydrolase | 0.015 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.015 | ||
| CD22 | CD22 molecule | 0.015 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.014 | ||
| CECR1 | cat eye syndrome chromosome region, candidate 1 | 0.014 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.014 | ||
| EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 | 0.014 | ||
| BEST1 | bestrophin 1 | 0.014 | ||
| SIRPA | signal-regulatory protein alpha | 0.014 | ||
| EPOR | erythropoietin receptor | 0.014 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.014 | ||
| KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | 0.014 | ||
| SLAMF8 | SLAM family member 8 | 0.014 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.014 | ||
| DPEP2 | dipeptidase 2 | 0.014 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.014 | ||
| TYMP | thymidine phosphorylase | 0.014 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.014 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.014 | ||
| GPR132 | G protein-coupled receptor 132 | 0.014 | ||
| PYDC2 | pyrin domain containing 2 | 0.013 | ||
| TXNDC3 | thioredoxin domain containing 3 (spermatozoa) | 0.013 | ||
| TRANK1 | tetratricopeptide repeat and ankyrin repeat containing 1 | 0.013 | ||
| CD300A | CD300a molecule | 0.013 | ||
| SLAMF7 | SLAM family member 7 | 0.013 | ||
| FOLR3 | folate receptor 3 (gamma) | 0.013 | ||
| APOBEC3C | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C | 0.013 | ||
| TAPBPL | TAP binding protein-like | 0.013 | ||
| BIN2 | bridging integrator 2 | 0.013 | ||
| P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 0.013 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.013 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.013 | ||
| ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 0.013 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.012 | ||
| FGB | fibrinogen beta chain | 0.012 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.012 | ||
| GBP4 | guanylate binding protein 4 | 0.012 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.012 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.012 | ||
| IL15 | interleukin 15 | 0.012 | ||
| TRIM6-TRIM34 | TRIM6-TRIM34 readthrough | 0.012 | ||
| PLXNA1 | plexin A1 | 0.012 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
| BCL2A1 | BCL2-related protein A1 | 0.011 | ||
| APP | amyloid beta (A4) precursor protein | 0.011 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.011 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.011 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.011 | ||
| KIR2DL3 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 | 0.011 | ||
| KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 0.011 | ||
| RAB7L1 | RAB7, member RAS oncogene family-like 1 | 0.011 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.011 | ||
| IRF5 | interferon regulatory factor 5 | 0.011 | ||
| BPI | bactericidal/permeability-increasing protein | 0.011 | ||
| GIMAP2 | GTPase, IMAP family member 2 | 0.011 | ||
| LY86 | lymphocyte antigen 86 | 0.011 | ||
| AGAP1 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 | 0.011 | ||
| APOBR | apolipoprotein B receptor | 0.011 | ||
| C17orf60 | chromosome 17 open reading frame 60 | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.010 | ||
| BAX | BCL2-associated X protein | 0.010 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.010 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.010 | ||
| CCL24 | chemokine (C-C motif) ligand 24 | 0.010 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.010 | ||
| ETV7 | ets variant 7 | 0.010 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.010 |